New toxic pathway identified for protein aggregates in neurodegenerative disease

March 17, 2017

Led by professor Ludo Van Den Bosch (VIB-KU Leuven), scientists from Belgium, the UK and the US have identified new processes that form protein "clumps" that are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). How these proteins, which can bind RNA in normal cells, stick together has remained elusive until recently, when scientists demonstrated that they demix from the watery substance inside cells, much like oil separates from water. Prof. Van Den Bosch's team sheds light onto the molecular interactions behind the process in patients with defects in the C9orf72 gene. Their results are featured on the cover of the leading journal Molecular Cell.

Clumps of RNA-binding proteins occur naturally in normal neurons under times of stress in the form of stress granules (SGs), which precipitate from the water inside cells. However, in , the process of stress granule formation is tightly controlled, reversible and does not lead to disease. Scientists previously believed that hydrophobic interactions – or the 's inability to mix with water – caused the formation of stress granules. However, Dr. Steven Boeynaems and colleagues under guidance of Prof. Van Den Bosch showed that in patients with defects in the C9orf72 gene, a different process can also cause this demixing, which precedes the formation of these toxic protein aggregates.

Mutation makes it easier for proteins to aggregate

Stress granules normally behave as liquid protein droplets within in a cell, while protein aggregates do not. The C9orf72 mutation causes neurons to produce small, abnormal and highly-charged toxic proteins, or peptides. Yet, precisely how these peptides are toxic was not well-understood. The research team was able to observe in vitro that these peptides cause RNA-binding proteins to spontaneously stick together and change the dynamics of in cells, making them more like solids than liquids.

Prof. Ludo Van Den Bosch (VIB-KU Leuven): "These observations give us more insight into the molecular process that leads to the clumping of RNA-binding protein in familial ALS and FTLD. It is believed that this process is an important step that occurs before the irreversible 'sticking-together' of the proteins, which is a pathological hallmark of these diseases. When enough of these clumps form, the neuron is unable to function and dies."

Protein clump 'antifreeze'

A multidisciplinary approach was vital to the study, with the lab of prof. Peter Tompa (VIB-VUB) and the Switch Laboratory (VIB-KU Leuven) collaborating closely with prof. Van Den Bosch's lab. These research groups' expertise in protein aggregation and structural biology was essential to the work. VIB's mass spectrometry core facility also played a pivotal role in identifying which proteins were responsive to the conditions created by the toxic peptides.

Dr. Steven Boeynaems (VIB-KU Leuven): "Based on our collaborative work, future studies could center around developing a molecular 'antifreeze' that prevents these liquid proteins from solidifying, thereby stopping protein aggregation and the death of neurons."

Explore further: Important role of nucleocytoplasmic transport in amyotrophic lateral sclerosis and frontotemporal dementia

More information: Steven Boeynaems et al. Phase Separation ofC9orf72Dipeptide Repeats Perturbs Stress Granule Dynamics, Molecular Cell (2017). DOI: 10.1016/j.molcel.2017.02.013

Related Stories

Important role of nucleocytoplasmic transport in amyotrophic lateral sclerosis and frontotemporal dementia

February 12, 2016
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating adult-onset neurodegenerative disorders. No cure exists for these diseases. Ten percent of ALS patients suffer from a familial form ...

Researchers identify new pathway leading to Alzheimer's disease

May 5, 2016
A newly discovered pathway leading to neurodegeneration in Alzheimer's disease (AD) may unlock the door to new approaches for treating the disease.

Link identified between nerve cell proteins and middle-age onset dementia

February 13, 2017
Nagoya University-led research identifies role for neuronal protein interaction in preventing frontotemporal lobar degeneration, a dementia that starts in middle age.

Study gives clues to causes of Motor Neurone Disease and Parkinson's Disease

March 10, 2017
Scientists at the University of Bath have made further progress to understanding the role of one of the proteins that causes the neurodegenerative disorder Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).

Toxic peptides disrupt membrane-less organelles in neurodegenerative disease

October 20, 2016
Researchers at St. Jude Children's Research Hospital have discovered the way toxic proteins linked to the most common forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) incapacitate membrane-less ...

Recommended for you

Researchers discover spinal cord neurons that inhibit distracting input to focus on task at hand

December 8, 2017
We think of our brain as masterminding all of our actions, but a surprising amount of information related to movement gets processed by our spinal cord.

The mysterious case of the boy missing most of his visual cortex who can see anyway

December 8, 2017
(Medical Xpress)—A team of researchers with Monash University recently gave a presentation at a neuroscience conference in Australia outlining their study of the brain of a seven-year-old boy who was missing most of his ...

How a seahorse-shaped brain structure may help us recognize others

December 8, 2017
How do we recognize others? How do we know friend from foe, threat from reward? How does the brain compute the multitude of cues telling us that Susan is not Erica even though they look alike? The complexity of social interactions—human ...

Brain networks that help babies learn to walk ID'd

December 8, 2017
Scientists have identified brain networks involved in a baby's learning to walk—a discovery that eventually may help predict whether infants are at risk for autism.

Why we can't always stop what we've started

December 7, 2017
When we try to stop a body movement at the last second, perhaps to keep ourselves from stepping on what we just realized was ice, we can't always do it—and Johns Hopkins University neuroscientists have figured out why.

Mutations in neurons accumulate as we age: The process may explain normal cognitive decline and neurodegeneration

December 7, 2017
Scientists have wondered whether somatic (non-inherited) mutations play a role in aging and brain degeneration, but until recently there was no good technology to test this idea. A study published online today in Science, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.